Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
Clinical trial NCT04087876 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04087876
- Sponsor
- Basilea Pharmaceutica
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.